Stephanie Hatch
Senior Research Scientist
Stephanie joined the HTS group in April 2016. She is responsible for developing and running high throughput screens, including ELISAs and various cellular phenotypic screens. Previously she performed cell-based assays as part of the Structural Genomic Consortium. She obtained her PhD from the University of North Carolina, Chapel Hill.
Recent publications
-
Data from Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Other
Rieunier G. et al, (2023)
-
Supplementary Data from Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Other
Rieunier G. et al, (2023)
-
Supplementary Data from Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction
Other
Rieunier G. et al, (2023)
-
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
Journal article
Emmenegger M. et al, (2023), iScience
-
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
Journal article
Vihta KD. et al, (2022), Clin Infect Dis, 75, e329 - e337